About this Blog
The coronavirus (COVID-19) pandemic has not left any country spared and health systems face challenges on multiple fronts. Cardiovascular disease is the world’s largest cause of morbidity and mortality. It is emerging as a common risk factor at baseline in the individuals most likely to have poor outcomes from COVID-19 infection. There is little yet known about the potential cardiac complications which may occur following COVID-19 infection, and there are many questions to be answered, whether through epidemiology and basic science or trials and pharmacology. In this blog, “The Heart in the Time of COVID-19”, WHF Emerging Leaders combine global perspective with updates of relevant the most recent science relating to cardiovascular disease and COVID-19. We hope this knowledge will be shared widely and together we can learn how to prevent and treat this disease which is truly unprecedented in its scale.
by: Amitava Banerjee and Pablo Perel
Please click here for a table of contents.
Latest from the Blog
by: Amitava Banerjee The countries which have been unable to suppress SARS-CoV-2 infection rate have had to focus health systems and resources on the acute hospitalised phase of COVID-19, particularly in the intensive care unit. However, most hospital care of COVID is not in intensive care, and most COVID patients, even in high-income settings, areContinue reading “The long cardiovascular tail of the pandemic”
by:Aaysha Cader Whilst much has been written about COVID-19 and its inflammation-thrombosis-hypercoagulability cascade, this has to a large extent focused on venous thromboembolism (VTE). As more data emerges, it is evident that the intense inflammatory response associated with SARS-COV-2 infection may trigger thrombosis across multiple vascular beds, with large thrombus burden in ST-segment elevation myocardialContinue reading “Do COVID STEMIs have a higher thrombus burden? More questions & implications”
by:Abraham Samuel Babu Cardiac rehabilitation (CR) is an integral part of cardiovascular care. Yet, it is one of the most underutilised evidence based intervention across the world.1 With uptake to CR varying greatly around the world, the novel 2019 coronavirus (COVID19), has been no help to this. Nevertheless, this has brought the entire CR communityContinue reading “Cardiac rehabilitation in the time of COVID19”
Get new content delivered directly to your inbox.